Meanwhile, the 3 × Tg-AD mouse model manifests cognitive impairment at 4 months as a deficit in long-term retention, but develops Aβ accumulation at approximately 6–9 months of age, and tau pathology starting at a slightly later age [29, 63]. This evidence concerns the gene MAPT and Alzheimer disease.